PCS Software adds new contactless features to expand TMS platform

PCS Software adds new contactless features to expand TMS platform

Published: 19 hours ago By Pankaj Singh

With this addition, it is now possible for PCS consumers to effectively manage their workflows using their mobile devices Document digitization has paved way for a safer and more sanitized workplace considering the current COVID-19 situa....

ODP teams up with Microsoft to support shared & new B2B customers

The ODP Corporation, an American retail company, has recently announced the expansion of its long-standing relationship with Microsoft. The two companies are planning to boost efficiencies and growth of their shared as well as new B2B custo....

Gannex reveals positive data from ASC41 clinical study in 20 subjects

Ascletis Pharma Inc.’s wholly-owned company, Gannex, has reportedly announced the positive clinical data from its ASC41 trial conducted among overweight and obese subjects. The active metabolite of this liver-targeted prodrug is selec....

Personalis & Natera enter partnership to boost personalized oncology

Personalis, Inc., a cancer genomics company, has recently entered a partnership deal with Natera, Inc., a leading provider of cell-free DNA testing, to advance personalized oncology. Under this agreement, the NeXT tumor profiling & diag....

AiFi, Wundermart to partner for autonomous convenience stores launch

Retail technology private company, AiFi, has reportedly joined forces with Wundermart, to initially launch over 20 autonomous convenience stores in the first quarter of 2021. For the record, the latter company creates unmanned, data-driven ....

HEINEKEN to deploy ML-powered demand planning solution of Blue Yonder

HEINEKEN, an international brewer, has reportedly extended its relationship with a software and consultancy company, Blue Yonder, to drive its demand planning capabilities. The brewing company will implement the ML-powered demand planning s....

GenSight announces results from Phase I/lla trial REVEAL in BioDrugs

GenSight Biologics, a biotechnology company, has recently announced the results from the Phase I/lla clinical trial, REVEAL, in the peer-reviewed journal, BioDrugs. This clinical trial has been conducted with an aim to examine the safety of....

Industry Updates